REFINE · 101MS206
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A randomized, blinded, parallel-group phase 2 study exploring the safety, tolerability and efficacy of multiple natalizumab dosing regimens in adults with relapsing multiple sclerosis. EudraCT: 2010-024000-10.
Sponsor: BIOGEN
Phase: II
Area: Neuroimmunology